Changeflow GovPing Healthcare & Life Sciences Magnetically Immobilized Microbiocidal Enzymes,...
Routine Notice Added Final

Magnetically Immobilized Microbiocidal Enzymes, ZYMtronix, 15th Apr

Favicon for changeflow.com EPO Patent Bulletin - Biotech (C12N)
Published
Detected
Email

Summary

The European Patent Office published patent application EP3297442A1 titled 'Magnetically Immobilized Microbiocidal Enzymes' filed by ZYMtronix, Inc. The invention relates to the use of magnetically immobilized microbiocidal enzymes for antimicrobial applications. The patent application was published on 15 April 2026 under EPC procedure, with designated states covering all EU member states plus associated countries.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The European Patent Office published patent application EP3297442A1 for 'Magnetically Immobilized Microbiocidal Enzymes' filed by ZYMtronix, Inc. (inventor: CORGIE, Stephane). The application is classified under IPC A01N 63/02 and C12N 11/18, covering biotechnological methods for enzyme immobilization with antimicrobial properties.

Affected parties include the applicant ZYMtronix, Inc. seeking European patent protection, potential competitors in the biocatalysis or antimicrobial enzyme space, and licensees interested in commercializing magnetically immobilized enzyme technology. Third parties have the standard opportunity to challenge the patent during the nine-month opposition period following publication.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

MAGNETICALLY IMMOBILIZED MICROBIOCIDAL ENZYMES

Publication EP3297442A1 Kind: A1 Apr 15, 2026

Applicants

ZYMtronix, Inc.

Inventors

CORGIE, Stephane

IPC Classifications

A01N 63/02 20060101AFI20181001BHEP C12N 11/18 20060101ALI20181001BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Notice
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP3297442A1

Who this affects

Applies to
Manufacturers Pharmaceutical companies
Industry sector
3254.1 Biotechnology
Activity scope
Patent filing Biocatalysis research
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!